Cited 3 times in
Loss of DUSP4 Expression as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신수진 | - |
dc.date.accessioned | 2022-02-23T01:10:42Z | - |
dc.date.available | 2022-02-23T01:10:42Z | - |
dc.date.issued | 2021-10 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/187573 | - |
dc.description.abstract | Dual-specificity protein phosphatase 4 (DUSP4) is a negative regulator of mitogen-activated protein kinases. The prognostic impact of DUSP4 expression in renal cell carcinoma is not well studied. Therefore, we evaluated the clinicopathological implications of DUSP4 expression in clear cell renal cell carcinoma by performing immunohistochemistry (IHC). The clinical outcome according to DUSP4 expression was evaluated through survival analyses, and the association between mRNA expression and prognosis was confirmed by online analysis (Kaplan-Meier plotter). Loss of DUSP4 expression was noted in most histological subtypes of renal cell carcinoma. Loss of DUSP4 expression in clear cell renal cell carcinoma was significantly correlated with old age (p = 0.033), high histologic grade (p < 0.001), tumor necrosis (p < 0.001), and high pT category (p < 0.001). In survival analysis, loss of DUSP4 expression was associated with poor clinical outcomes in cancer-specific survival and recurrence-free survival (p = 0.010 and p = 0.007, respectively). Upon TCGA data analysis, patients with low DUSP4 mRNA expression showed a shorter overall survival (p = 0.023). These results suggest that loss of DUSP4 expression can be used as a potential biomarker for predicting clinical outcomes in clear cell renal cell carcinoma patients. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | MDPI AG | - |
dc.relation.isPartOf | DIAGNOSTICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Loss of DUSP4 Expression as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pathology (병리학교실) | - |
dc.contributor.googleauthor | Seongsik Bang | - |
dc.contributor.googleauthor | Seungyun Jee | - |
dc.contributor.googleauthor | Hwangkyu Son | - |
dc.contributor.googleauthor | Young Chan Wi | - |
dc.contributor.googleauthor | Hyunsung Kim | - |
dc.contributor.googleauthor | Hosub Park | - |
dc.contributor.googleauthor | Jaekyung Myung | - |
dc.contributor.googleauthor | Su-Jin Shin | - |
dc.contributor.googleauthor | Seung Sam Paik | - |
dc.identifier.doi | 10.3390/diagnostics11101939 | - |
dc.contributor.localId | A04596 | - |
dc.relation.journalcode | J03798 | - |
dc.identifier.eissn | 2075-4418 | - |
dc.identifier.pmid | 34679636 | - |
dc.subject.keyword | DUSP4 | - |
dc.subject.keyword | dual-specificity protein phosphatase 4 | - |
dc.subject.keyword | prognosis | - |
dc.subject.keyword | renal cell carcinoma | - |
dc.contributor.alternativeName | Shin, Su Jin | - |
dc.contributor.affiliatedAuthor | 신수진 | - |
dc.citation.volume | 11 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1939 | - |
dc.identifier.bibliographicCitation | DIAGNOSTICS, Vol.11(10) : 1939, 2021-10 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.